Occudo Quantitative Strategies’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Occudo Quantitative Strategies’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,925	Closed	-$55.7K	–	1061
2024 Q1	$55.7K	Sell	20,925 -48,888	-70%	-$121K	0.01%	688
2023 Q4	$165K	Buy	+69,813	New	+$124K	0.02%	669
2023 Q3	–	Sell	-15,435	Closed	-$46.8K	–	1389
2023 Q2	$46.8K	Buy	+15,435	New	+$59.5K	﹤0.01%	961

Occudo Quantitative Strategies's KNTE Position: Q2 2024 in Review

Occudo Quantitative Strategies sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 20,925 shares — an estimated $55.7K sold.

Occudo Quantitative Strategies first reported a position in KNTE in Q2 2023 and held it in 3 quarters. The position peaked at $165K in Q4 2023. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

Occudo Quantitative Strategies reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Occudo Quantitative Strategies sold 20,925 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $55.7K.
Occudo Quantitative Strategies first reported a position in Kinnate Biopharma Inc. Common Stock in Q2 2023 and held it in 3 quarters.
Occudo Quantitative Strategies's Kinnate Biopharma Inc. Common Stock position peaked at $165K in Q4 2023.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.